𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ribavirin treatment in murine autoimmune disease

✍ Scribed by Lynell W. Klassen; Gary W. Williams; James L. Reinertsen; N. Lynn Gerber; Alfred D. Steinberg


Publisher
John Wiley and Sons
Year
1979
Tongue
English
Weight
786 KB
Volume
22
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Gene therapy in the treatment of autoimm
✍ Peter M. Mathisen; Vincent K. Tuohy πŸ“‚ Article πŸ“… 1998 πŸ› Elsevier Science 🌐 English βš– 323 KB

he in vivo local delivery of regulatory cytokines made possible by gene therapy is becoming an exciting approach for treating common disorders such as cancer and viral infections I. Recently, gene therapy strategies have been applied to the treatment of autoimmune diseases. Cells targeted for autoim

The involvement of IL-12 in murine exper
✍ Paola Zaccone; Paddy Hutchings; Ferdinando Nicoletti; Giuseppe Penna; Luciano Ad πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 147 KB πŸ‘ 2 views

Experimental autoimmune thyroid disease (EAT) can be induced experimentally in mice following immunization with mouse thyroglobulin (mTg) and the adjuvants lipopolysaccharide (LPS) or complete Freund's adjuvant (CFA). EAT can also be transferred to naive recipients by CD4 + T cells from mTg-primed m

APOPTOSIS IN AUTOIMMUNE AND NON-AUTOIMMU
✍ LUDGATE, MARIAN; JASANI, BHARAT πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 239 KB πŸ‘ 2 views

The elimination of autoreactive T cells in the thymus involves the process of programmed cell death. Animal model studies, using the lpr and gld strains of mice, have identified FAS receptor (FAS) and FAS ligand (FAS-L) as important components of this mechanism. Whether FAS and FAS-L are also implic

Dendritic cells in tolerance induction f
✍ Maria Rescigno πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 248 KB πŸ‘ 2 views

## Abstract Autoimmune diseases are characterized by the loss of tolerance toward self‐antigens and the induction of destructive immune responses leading to tissue damage. Most patients with autoimmune diseases are treated with immunosuppressive drugs that suppress the immune response in a non‐spec